AKT1 and familial pancreatic carcinoma: In the present study, nude mice with human pancreatic cancer were treated with different concentrations of KLT and the resulting changes in the tumor growth inhibition rate, apoptosis, and protein expression levels of PI3K/Akt/mTOR pathway components were measured to explore the therapeutic mechanism of KLT in pancreatic cancer.